Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDK2 | Q15119 | 10/20 | 0.41 |
| ▸ | TDP2 | O95551 | 1/20 | 0.36 |
| ▸ | PGR | P06401 | 4/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
| ▸ | MAPT | P10636 | 2/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.35 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 2/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.34 |
| ▸ | ATM | Q13315 | 2/20 | 0.34 |
| ▸ | CRHBP | P24387 | 1/20 | 0.34 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.34 |
| ▸ | TLR9 | Q9NR96 | 1/20 | 0.34 |
| ▸ | APAF1 | O14727 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16366391 | 1.00 | PDK2 (0.41) | PDK2TDP2PGRL3MBTL1ALDH1A1 | |
| SCHEMBL17153716 | 1.00 | PDK2 (0.41) | PDK2TDP2PGRL3MBTL1ALDH1A1 | |
| SCHEMBL16366127 | 1.00 | PDK2 (0.41) | PDK2TDP2PGRL3MBTL1ALDH1A1 | |
| SCHEMBL15496209 | 1.00 | PDK2 (0.41) | PDK2TDP2PGRL3MBTL1ALDH1A1 | |
| SCHEMBL17153690 | 1.00 | PDK2 (0.41) | PDK2TDP2PGRL3MBTL1ALDH1A1 | |
| SCHEMBL24923289 | 1.00 | PDK2 (0.41) | PDK2TDP2PGRL3MBTL1ALDH1A1 | |
| SCHEMBL16366387 | 1.00 | PDK2 (0.41) | PDK2TDP2PGRL3MBTL1ALDH1A1 | |
| SCHEMBL16366403 | 1.00 | PDK2 (0.41) | PDK2TDP2PGRL3MBTL1ALDH1A1 | |
| SCHEMBL16922969 | 1.00 | PDK2 (0.41) | PDK2TDP2PGRL3MBTL1ALDH1A1 | |
| SCHEMBL17153624 | 1.00 | PDK2 (0.41) | PDK2TDP2PGRL3MBTL1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9871203-B2 | Aromatic amine derivative, organic electroluminescent element and electronic device | IDEMITSU KOSAN CO., LTD. (JP) | 2018-01-16 | — | — | US | disclosed |
| US-9871203-B2 | Aromatic amine derivative, organic electroluminescent element and electronic device | IDEMITSU KOSAN CO., LTD. (JP) | 2018-01-16 | — | — | US | disclosed |
| US-20150287921-A1 | AROMATIC AMINE DERIVATIVE, ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2015-10-08 | — | — | US | disclosed |
| US-20150287921-A1 | AROMATIC AMINE DERIVATIVE, ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2015-10-08 | — | — | US | disclosed |
| EP-2816025-A1 | AROMATIC AMINE DERIVATIVE, ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE | Idemitsu Kosan Co., Ltd (JP) | 2014-12-24 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150287921-A1 | AROMATIC AMINE DERIVATIVE, ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE | RER1, AFF1, ESR2 | PDK2 3794/4885TDP2 3085/4885PGR 720/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.